Approval for the tacticath quartz catheter and tactisysquartz equipment. this device is indicated for use in cardiacelectrophysiological mapping and for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used in conjunction with a compatible radiofrequency generator and three-dimensional mapping system.